Your browser doesn't support javascript.
loading
Trends of measles in Tanzania: A 5-year review of case-based surveillance data, 2018-2022.
Michael, Fausta; Mirambo, Mariam M; Misinzo, Gerald; Minzi, Omary; Beyanga, Medard; Mujuni, Delphinus; Kalabamu, Florence S; Nyanda, Elias N; Mwanyika-Sando, Mary; Ndiyo, Daniel; Kasonogo, Richard; Ismail, Abbas; Bahati, Andrew; Hassan, Farida; Kaale, Eliangiringa; Chai, John J; Kinyunyi, Pricillah; Kyesi, Furaha; Tinuga, Florian; Mongi, Dhamira; Salehe, Abdul; Muhindi, Bonaventura; Mdachi, Joseph; Magodi, Richard; Mwenesi, Mwendwa; Nyaki, Honest; Katembo, Betina; Tenga, Kelvin; Kasya, Magdalena; Mwengee, Willliam; Mshana, Stephen E.
Afiliación
  • Michael F; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Mirambo MM; Department of Microbiology and Immunology, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
  • Misinzo G; OR Tambo Africa Research Chair for Viral Epidemics, SACIDS Foundation for One Health, Sokoine University of Agriculture, Morogoro, Tanzania.
  • Minzi O; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Beyanga M; National Public Health Laboratory, Ministry of Health, Dar es Salaam, Tanzania.
  • Mujuni D; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Kalabamu FS; Department of Pediatrics and Child Health, Hubert Kairuki Memorial University, Dar es Salaam, Tanzania.
  • Nyanda EN; Mbeya Medical Research Centre, National Institute for Medical Research, Mbeya, Tanzania.
  • Mwanyika-Sando M; Africa Academy for Public Health, Mikocheni, Dar es Salaam, Tanzania.
  • Ndiyo D; Directorate of Regulatory Services, Government Chemist Laboratory Authority, Dodoma, Tanzania.
  • Kasonogo R; Tanzania Medicines and Medical Devices Authority, Ministry of Health, Dodoma, Tanzania.
  • Ismail A; Department of Mathematics and Statistics, University of Dodoma, Dodoma, Tanzania.
  • Bahati A; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Hassan F; Health System, Impact Evaluation and Policy, Ifakara Health Institute, Ifakara, Tanzania.
  • Kaale E; Pharm R&D Lab and Department of Medicinal Chemistry, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Chai JJ; District Court of Kwimba, Judiciary of Tanzania, Ngudu, Tanzania.
  • Kinyunyi P; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Kyesi F; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Tinuga F; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Mongi D; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Salehe A; Immunization and Vaccine Development Program, Ministry of Health, Mnazimmoja, Zanzibar.
  • Muhindi B; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Mdachi J; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Magodi R; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Mwenesi M; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Nyaki H; Immunization and Vaccine Development Program, Ministry of Health, Dodoma, Tanzania.
  • Katembo B; National Public Health Laboratory, Ministry of Health, Dar es Salaam, Tanzania.
  • Tenga K; National Public Health Laboratory, Ministry of Health, Dar es Salaam, Tanzania.
  • Kasya M; National Public Health Laboratory, Ministry of Health, Dar es Salaam, Tanzania.
  • Mwengee W; World Health Organization, Dar es Salaam, Tanzania.
  • Mshana SE; Department of Microbiology and Immunology, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania. Electronic address: stephen72mshana@gmail.com.
Int J Infect Dis ; 139: 176-182, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38122965
ABSTRACT

OBJECTIVES:

Tanzania observed a gradual increase in the number of measles cases since 2019 with a large outbreak recorded during 2022. This study describes the trend of measles in Tanzania over a 5-year period from 2018-2022.

METHODS:

This was a descriptive study conducted using routine measles case-based surveillance system including 195 councils of the United Republic of Tanzania.

RESULTS:

Between 2018 and 2022 there were 12,253 measles cases reported. Out of 10,691 (87.25%) samples tested by enzyme-linked immunosorbent assay, 903 (8.4%) were measles immunoglobulin M positive. The highest number of laboratory-confirmed measles cases was in 2022 (64.8%), followed by 2020 (13.8%), and 2019 (13.5%). Out of 1279 unvaccinated cases, 213 (16.7%) were laboratory-confirmed measles cases compared to 77/723 (10.6%) who were partially vaccinated and 71/1121 (6.3%) who were fully vaccinated (P < 0.001). Children aged between 1-4 years constituted the most confirmed measles cases after laboratory testing, followed by those aged 5-9 years. There was a notable increase in the number of laboratory-confirmed measles cases in children <1 year and 10-14 years during 2022 compared to previous years. The vaccination coverage of the first dose of measles-containing vaccine (MCV1) was maintained >90% since 2013 while MCV2 increased gradually reaching 88% in 2022.

CONCLUSIONS:

Accumulation of susceptible children to measles due to suboptimal measles vaccination coverage over the years has resulted in an increase in the number of laboratory-confirmed measles cases in Tanzania with more cases recorded during the COVID-19 pandemic. Strengthening surveillance, routine immunization, and targeted strategies are key to achieving the immunity levels required to interrupt measles outbreaks.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pandemias / Sarampión Límite: Child / Child, preschool / Humans / Infant País/Región como asunto: Africa Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Tanzania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pandemias / Sarampión Límite: Child / Child, preschool / Humans / Infant País/Región como asunto: Africa Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Tanzania